![](/img/cover-not-exists.png)
052 Efficacy of ixekizumab in moderate-to-severe psoriasis patients who have or have not received prior biologic therapies: An integrated analysis of 3 phase 3 studies
Gottlieb, A., Gerdes, S., Lacour, J., Korman, N., Papp, K., Dutronic, Y., Mallbris, L., Erickson, J., Schacht, A., Bachelez, H.Volume:
136
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2016.06.069
Date:
September, 2016
File:
PDF, 57 KB
english, 2016